![](/img/cover-not-exists.png)
Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis
Botrel, Tobias, Clark, Otávio, Paladini, LucianoLanguage:
english
Journal:
Core Evidence
DOI:
10.2147/CE.S50474
Date:
September, 2013
File:
PDF, 509 KB
english, 2013